SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Toevoegen aan een lijst
Financiën Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
Aandelen
300760
CNE100003G67
Geavanceerde medische apparatuur & technologie
|
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
| 299,3 CNY | +0,32% |
|
-2,01% | +3,01% |
| 20/05 | Shenzhen Mindray Bio-Medical Electronics Co, Ltd. Keurt Slotdividend voor het Jaar 2023 goed | CI |
| 29/04 | SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. : Nomura handhaaft koopadvies | ZM |
Totale waarde
| Fiscaal tijdperk: december | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Marktkapitalisatie 1 | 221.134 | 517.884 | 461.774 | 382.132 | 351.450 | 362.020 | - | - |
| Bedrijfswaarde 1 | 206.861 | 502.020 | 446.498 | 359.043 | 332.776 | 337.507 | 330.081 | 321.530 |
| K/w-verhouding | 47,2 x | 77,8 x | 57,8 x | 39,8 x | 30,4 x | 26 x | 21,8 x | 18,3 x |
| Dividendrendement | 0,82% | 0,59% | 0,92% | 1,42% | 0,52% | 2,24% | 2,69% | 3,18% |
| Marktkapitalisatie/omzet | 13,4 x | 24,6 x | 18,3 x | 12,6 x | 10,1 x | 8,67 x | 7,25 x | 6,15 x |
| Bedrijfswaarde/omzet | 12,5 x | 23,9 x | 17,7 x | 11,8 x | 9,53 x | 8,08 x | 6,61 x | 5,47 x |
| Bedrijfswaarde/EBITDA | 35,8 x | 63,3 x | 45,7 x | 30,4 x | 23,8 x | 21,1 x | 17,2 x | 14,3 x |
| Bedrijfswaarde/FCF | 52,4 x | 65,3 x | 58,6 x | 34,9 x | 39,6 x | 29,8 x | 21,9 x | 18,6 x |
| FCF Yield | 1,91% | 1,53% | 1,71% | 2,87% | 2,52% | 3,36% | 4,57% | 5,38% |
| Price to Book | 11,9 x | 22,2 x | 17,2 x | 12 x | 10,6 x | 8,53 x | 6,89 x | 5,68 x |
| Aantal aandelen (in duizenden) | 1.215.691 | 1.215.691 | 1.212.643 | 1.209.393 | 1.209.393 | 1.209.393 | - | - |
| Referentieprijs 2 | 181,9 | 426,0 | 380,8 | 316,0 | 290,6 | 299,3 | 299,3 | 299,3 |
| Datum van publicatie | 27-02-20 | 28-04-21 | 19-04-22 | 27-04-23 | 26-04-24 | - | - | - |
1CNY in Miljoen2CNY
Geschatte gegevens
Evolutie van de resultatenrekening (Jaargegevens)
| Fiscaal tijdperk: december | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Omzet 1 | 16.556 | 21.026 | 25.270 | 30.366 | 34.932 | 41.758 | 49.955 | 58.834 |
| EBITDA 1 | 5.784 | 7.930 | 9.766 | 11.796 | 13.995 | 16.019 | 19.137 | 22.440 |
| Bedrijfsresultaat (EBIT) 1 | 5.379 | 7.455 | 9.066 | 10.991 | 13.070 | 15.341 | 18.448 | 21.823 |
| Operationele Marge | 32,49% | 35,46% | 35,88% | 36,19% | 37,42% | 36,74% | 36,93% | 37,09% |
| Resultaat voor belastingen (EBT) 1 | 5.368 | 7.438 | 9.017 | 10.954 | 13.011 | 15.755 | 18.886 | 22.451 |
| Nettowinst (verlies) 1 | 4.681 | 6.658 | 8.002 | 9.607 | 11.582 | 13.947 | 16.687 | 19.839 |
| Nettomarge | 28,27% | 31,66% | 31,66% | 31,64% | 33,16% | 33,4% | 33,4% | 33,72% |
| WPA 2 | 3,850 | 5,476 | 6,587 | 7,937 | 9,558 | 11,49 | 13,75 | 16,35 |
| Free Cash Flow 1 | 3.949 | 7.690 | 7.618 | 10.299 | 8.395 | 11.329 | 15.079 | 17.314 |
| FCF-marge | 23,85% | 36,58% | 30,15% | 33,92% | 24,03% | 27,13% | 30,18% | 29,43% |
| Kasstroomconversie (ebitda) | 68,27% | 96,97% | 78% | 87,31% | 59,99% | 70,72% | 78,79% | 77,16% |
| Kasstroomconversie (nettowinst) | 84,37% | 115,51% | 95,21% | 107,2% | 72,48% | 81,22% | 90,36% | 87,27% |
| Dividend per aandeel 2 | 1,500 | 2,500 | 3,500 | 4,500 | 1,500 | 6,700 | 8,049 | 9,520 |
| Datum van publicatie | 27-02-20 | 28-04-21 | 19-04-22 | 27-04-23 | 26-04-24 | - | - | - |
1CNY in Miljoen2CNY
Geschatte gegevens
Evolutie van de resultatenrekening (Kwartaalgegevens)
| Fiscaal tijdperk: december | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 S1 | 2022 Q3 | 2022 Q4 | 2022 S2 | 2023 Q1 | 2023 Q2 | 2023 S1 | 2023 Q3 | 2023 Q4 | 2023 S2 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Omzet 1 | 5.878 | 6.943 | 8.412 | 15.356 | 7.940 | 7.070 | 15.010 | 8.364 | 10.111 | 18.476 | 8.828 | 7.628 | 16.456 | 9.373 | 11.130 | 10.813 | 10.126 | 11.154 | 13.133 |
| EBITDA | 1.330 | 2.560 | 3.502 | - | 3.213 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Bedrijfsresultaat (EBIT) 1 | 1.471 | 2.402 | 3.604 | 6.005 | 3.214 | 1.771 | - | 2.900 | 4.430 | - | 3.871 | 1.869 | - | 3.572 | 4.046 | 4.213 | 3.417 | 3.814 | - |
| Operationele Marge | 25,02% | 34,59% | 42,84% | 39,11% | 40,48% | 25,06% | - | 34,67% | 43,81% | - | 43,85% | 24,5% | - | 38,11% | 36,35% | 38,96% | 33,75% | 34,19% | - |
| Resultaat voor belastingen (EBT) 1 | 1.434 | 2.406 | 3.603 | 6.008 | 3.220 | 1.725 | 4.945 | - | 4.422 | 7.310 | 3.877 | 1.824 | 5.701 | - | 3.928 | 4.186 | 4.033 | - | - |
| Nettowinst (verlies) 1 | 1.339 | 2.105 | 3.183 | 5.288 | 2.815 | 1.505 | 4.320 | - | 3.871 | 6.442 | 3.392 | 1.748 | 5.140 | - | 3.499 | 3.724 | 3.588 | - | - |
| Nettomarge | 22,77% | 30,32% | 37,83% | 34,43% | 35,45% | 21,29% | 28,78% | - | 38,28% | 34,87% | 38,43% | 22,91% | 31,24% | - | 31,44% | 34,44% | 35,43% | - | - |
| WPA 2 | 1,105 | 1,738 | 2,631 | - | 2,330 | 1,240 | - | 2,125 | 3,191 | - | 2,803 | 1,440 | - | 2,609 | 3,269 | 3,344 | 2,320 | 2,895 | 4,450 |
| Dividend per aandeel | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Datum van publicatie | 19-04-22 | 19-04-22 | 19-08-22 | 19-08-22 | 27-10-22 | 27-04-23 | 27-04-23 | 27-04-23 | 29-08-23 | 29-08-23 | 27-10-23 | 26-04-24 | 26-04-24 | 26-04-24 | - | - | - | - | - |
1CNY in Miljoen2CNY
Geschatte gegevens
Balans
| Fiscaal tijdperk: december | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Nettoschuldpositie 1 | - | - | - | - | - | - | - | - |
| Nettokaspositie 1 | 14.273 | 15.865 | 15.276 | 23.088 | 18.673 | 24.512 | 31.939 | 40.489 |
| Hefboom (schuld/ebitda) | - | - | - | - | - | - | - | - |
| Free Cash Flow 1 | 3.949 | 7.690 | 7.618 | 10.299 | 8.395 | 11.329 | 15.079 | 17.314 |
| ROE (netto-inkomsten/eigen vermogen) | 27,9% | 32,3% | 31,9% | 33,4% | 33,6% | 35,4% | 34,6% | 34,2% |
| ROA (netto-inkomsten/totale activa) | 19,8% | 22,6% | 22,4% | 22,6% | - | 25,3% | 25,6% | 26,2% |
| Totale activa 1 | 23.625 | 29.470 | 35.705 | 42.424 | - | 55.094 | 65.258 | 75.649 |
| Nettoactief per aandeel 2 | 15,30 | 19,10 | 22,20 | 26,40 | 27,30 | 35,10 | 43,50 | 52,70 |
| Cashflow per aandeel 2 | 3,880 | 7,300 | 7,400 | 10,00 | 9,120 | 12,00 | 14,30 | 16,80 |
| Capex 1 | 773 | 1.180 | 1.381 | 1.842 | 2.667 | 1.992 | 1.827 | 2.034 |
| Capex/omzet | 4,67% | 5,61% | 5,46% | 6,07% | 7,63% | 4,77% | 3,66% | 3,46% |
| Datum van publicatie | 27-02-20 | 28-04-21 | 19-04-22 | 27-04-23 | 26-04-24 | - | - | - |
1CNY in Miljoen2CNY
Geschatte gegevens
WPA & Dividend
Historische koers/winstverhouding
Evolutie van de historische prestaties
Historische marktkapitalisatie/EBITDA
Trading rating
Beleggingsrating
ESG Refinitiv
B+
Verkoop
Koop
Gemiddeld advies
Kopen
Aantal analisten
29
Laatste slotkoers
299,3
CNY
Gemiddelde koersdoel
393,8
CNY
Spread / Gemiddelde doel
+31,57%
Herzieningen van WPA
| Vaira. 1 jan. | Kapi. | |
|---|---|---|
| +3,01% | 49,8 mld. | |
| +6,88% | 219 mld. | |
| +10,72% | 192 mld. | |
| +17,93% | 142 mld. | |
| +29,63% | 111 mld. | |
| +2,09% | 65,32 mld. | |
| +13,97% | 52,45 mld. | |
| +4,43% | 43,43 mld. | |
| +1,37% | 35,95 mld. | |
| +19,60% | 30,43 mld. |
- Beurs
- Aandelen
- Koers 300760
- Financiën Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
